Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ · Healthcare
Citius Pharmaceuticals, Inc. Operating Income 2011–2022
Citius Pharmaceuticals, Inc. annual/quarterly operating income history and growth rate from 2011 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Citius Pharmaceuticals, Inc. operating income for the quarter ending March 31, 2026 was -32.2 M, a 64510.54% increase year-over-year.
- Citius Pharmaceuticals, Inc. operating income for the twelve months ending March 31, 2026 was -41.3 M, a 7950.15% increase year-over-year.
- Citius Pharmaceuticals, Inc. annual operating income for 2022 was -33.3 M, a 41.58% increase from 2021.
- Citius Pharmaceuticals, Inc. annual operating income for 2021 was -23.5 M, a 32.87% increase from 2020.
- Citius Pharmaceuticals, Inc. annual operating income for 2020 was -17.7 M, a 13.54% increase from 2019.
- Citius Pharmaceuticals, Inc. annual operating income for 2019 was -15.6 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Citius Pharmaceuticals, Inc. Operating Income — FAQ
Citius Pharmaceuticals, Inc. (CTXR) operating income over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
What is Citius Pharmaceuticals, Inc.'s operating income?
Citius Pharmaceuticals, Inc. (CTXR) reported operating income of -$33M for fiscal 2022.
Where can I see CTXR's operating income history?
The chart and table above show Citius Pharmaceuticals, Inc.'s operating income by year and by quarter, including the growth rate.